<DOC>
	<DOCNO>NCT02494284</DOCNO>
	<brief_summary>The purpose study compare short-term ( 6-month Dual Anti Platelet Therapy ( DAPT ) follow clopidogrel monotherapy ) vs. standard long-term dual antiplatelet strategy ( 24-month DAPT follow aspirin monotherapy ) clinically relevant bleeding complication ( Bleeding Academic Research Consortium ( BARC ) type 2 , 3 , 5 ) 31 patient zotarolimus-eluting stent implantation .</brief_summary>
	<brief_title>Short-Term Dual Antiplatelet Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Men woman least 19 year age Patients stable coronary artery disease successfully treat zotarolimuseluting stent Patients without major bleed MACE ( myocardial infarction , stent thrombosis , stoke , repeat revascularization ) within 6 month zotarolimuseluting stent placement The patient guardian agree study protocol schedule clinical followup , provide informed , write consent , approve appropriate Institutional Review Board/Ethical Committee respective clinical site . Persistent thrombocytopenia ( platelet count &lt; 100,000/Âµl ) A know intolerance study drug ( aspirin , clopidogrel ) Patients require longterm oral anticoagulant cilostazol Patients present acute myocardial infarction ( STEMI NSTEMI ) time index procedure Planned cardiac surgery ( e.g. , CABG , valve repair replacement , aneurysmectomy ) plan major noncardiac surgery within 18 month procedure Baremetal stent implantation time index procedure Chronic disease require treatment oral , intravenous , intraarticular corticosteroid ( use topical , inhaled , nasal corticosteroid permissible ) . A diagnosis cancer past 2 year current treatment active cancer . Any clinically significant abnormality identify screen visit , physical examination , laboratory test , electrocardiogram , judgment Investigator , would preclude safe completion study . Hepatic disease biliary tract obstruction , significant hepatic enzyme elevation ( ALT AST &gt; 3 time upper limit normal ) . History adult asthma manifest bronchospasm past 6 month , currently take regular antiasthmatic medication ( ) . Unwillingness inability comply procedure describe protocol . Patients pregnant breastfeed childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Coronary artery disease</keyword>
	<keyword>Dual antiplatelet platelet therapy</keyword>
	<keyword>Drug elute stent</keyword>
</DOC>